Key Details
Price
$0.05Annual ROE
-12.17%Beta
-Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
N/ARecent annual earnings:
N/ANext ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
No data about analysts updates
Screeners with EQRXW included
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
EQRx doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Similar stocks
FAQ
- What is the primary business of EQRx?
- What is the ticker symbol for EQRx?
- Does EQRx pay dividends?
- What sector is EQRx in?
- What industry is EQRx in?
- What country is EQRx based in?
- When did EQRx go public?
- Is EQRx in the S&P 500?
- Is EQRx in the NASDAQ 100?
- Is EQRx in the Dow Jones?
- When does EQRx report earnings?
What is the primary business of EQRx?
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. Its product pipeline in development includes Aumolertinib, an EGFR inhibitor for the treatment of ?EGFR-mutated? non-small cell lung cancer (NSCLC); Sugemalimab, an anti-PD-L1 antibody for the treatment of ?stage III and IV ?NSCLC; Lerociclib, a CDK4/6 inhibitor to treat HR+/HER2- breast cancer; and EQ176, an anti-PD-1?antibody for the treatment of liver cancer. The company has partnerships with Exscientia and AbCellera Biologics Inc. EQRx, Inc. was founded in 2020 and is based in Cambridge, Massachusetts.
What is the ticker symbol for EQRx?
The ticker symbol for EQRx is NASDAQ:EQRXW
Does EQRx pay dividends?
No, EQRx does not pay dividends
What sector is EQRx in?
EQRx is in the Healthcare sector
What industry is EQRx in?
EQRx is in the Biotechnology industry
What country is EQRx based in?
EQRx is headquartered in United States
When did EQRx go public?
EQRx's initial public offering (IPO) was on 20 December 2021
Is EQRx in the S&P 500?
No, EQRx is not included in the S&P 500 index
Is EQRx in the NASDAQ 100?
No, EQRx is not included in the NASDAQ 100 index
Is EQRx in the Dow Jones?
No, EQRx is not included in the Dow Jones index
When does EQRx report earnings?
The date for EQRx's next earnings report has not been announced yet